Raoom Trading Company SJSC

Raoom Trading Company SJSC exhibits a capital structure with a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position compared to industry norms. However, the company's liquidity position is rated as medium, with a current ratio of 9.78, suggesting strong short-term asset coverage of liabilities. Despite this, the company's free cash flow is negative at -28.67 million, driven by capital expenditures of -11.85 million, which may signal ongoing investment in operations or infrastructure.

Profitability metrics show mixed results. The company reported a net income of -4.64 million, translating to a negative return on equity of -3.37% and a return on assets of -2.39%. These figures fall below the industry median for both ROE and ROA, indicating underperformance relative to peers. The gross profit margin of 25.75% (26.67 million on 103.62 million revenue) is in line with the industry average, but the operating margin of 16.53% is slightly below the median for Commodity Chemicals firms.

Geographically, Raoom's revenue is concentrated in a single jurisdiction, with no disclosed international operations. The company's business is entirely attributed to its primary segment, which accounts for 100% of total revenue. This lack of diversification increases exposure to local economic and regulatory shifts.

The company's growth trajectory is uncertain. Revenue in the latest period was 103.62 million, but no year-over-year growth rate is available. The outlook for the current fiscal year is neutral, with no significant revenue expansion expected. The absence of a clear growth driver, combined with negative net income, suggests the company is in a stabilization phase rather than an expansion phase.

Risk factors include a negative net cash position after subtracting total debt, which could constrain operational flexibility. The company's dilution risk is rated as low, with no recent share issuance or shelf registration activity reported. However, the negative free cash flow and capital expenditures may necessitate future financing, which could introduce dilution pressure if equity is used to fund operations.

Recent filings and transcripts do not indicate any material events or strategic shifts. The company has not disclosed any new product launches, major contracts, or restructuring plans in the latest available documents. This lack of strategic activity may contribute to the flat revenue outlook and weak profitability.